A nomogram for predicting incontinence-associated dermatitis in Chinese patients with severe acute pancreatitis: a retrospective analysis

预测中国重症急性胰腺炎患者尿失禁相关性皮炎的列线图:一项回顾性分析

阅读:1

Abstract

OBJECTIVE: To identify the incidence of and risk factors for incontinence-associated dermatitis (IAD) among Chinese patients with severe acute pancreatitis (SAP) to facilitate the development of a predictive risk assessment model. METHODS: A prediction model was constructed using data from 302 SAP patients treated at West China Hospital, Sichuan University, from January 2020 to December 2022. The dataset was divided into training (n=183), testing (n=79), and external validation (n=40) sets. Predictors for incontinence-associated dermatitis were identified through univariate and multivariate logistic regression analyses. A nomogram was established to predict the occurrence of incontinence-associated dermatitis. Receiver operating characteristic (ROC) curves and the Hosmer-Lemeshow test were used to evaluate the model's performance. RESULTS: A total of 302 SAP patients showed a 57% incidence of IAD. Independent predictors included acute physiology and chronic health evaluation II scores of 15 or higher, fecal incontinence, stool frequency greater than 3 times per day, watery stool, and the use of herbal enemas. In the training set, the model showed an area under the ROC curve (AUC) of 0.836 (95% CI: 0.779-0.894), with sensitivity and specificity values of 86.5% and 66.7%, respectively. The testing set yielded an AUC of 0.825 (95% CI: 0.728-0.921), with sensitivity of 82.0% and specificity of 72.4%. External validation using an independent dataset produced an AUC of 0.788 (95% CI: 0.644-0.933), with a sensitivity of 92.9% and a specificity of 57.7%. CONCLUSION: The nomogram provides a simple and accurate tool for the prompt identification of patients with incontinence-associated dermatitis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。